Madhav Vasanthavada Sells $25.3K of Abeona Therapeutics Inc (ABEO) — SEC Form 4, Sep 30, 2026

Open-Market Net Sale · SEC Form 4

−$25,273

Equity position changed by -1.7%

Reporting Owner

Madhav Vasanthavada

Officer

TXN 2026-09-29 · FILED 2026-09-30

Equity Position 286K sh 290,623 → 285,721

Equity Change -1.7% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Abeona Therapeutics Inc

ABEO CIK 0000318306

Reporting Owner

Name	Relationship
Madhav Vasanthavada CIK 0002106295	Officer

Madhav Vasanthavada at Abeona Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $264,337

More from this insider at Abeona Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2026-09-29	S - Sale	4,902 D	$5.16	-$25,273	285,721	Direct

Footnotes (2)

F1: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. Show more
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1150 to $5.3000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 7 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Abeona Therapeutics Inc

GET /v1/forms/4/0001493152-26-044971 API docs